Clinical Study Results
Study Name
Title of the study: A Multicenter Double-blind, Randomized Controlled Study of
Etanercept and Methotrexate in Combination or as Monotherapy in
Subjects With Psoriatic Arthritis
Brief Title: How did Etanercept Alone and in Combination with Methotrexate
Improve Symptoms of Psoriatic Arthritis?
Protocol Number: 20130207
EU Trial Number 2014-004869-24
Other Identifiers NCT02376790
Date of This Summary 3 December 2019
What does this summary cover? devorppA
This summary shows the main results from one clinical study. The results are only for this
study. Other studies may find different results. Researchers and health authorities look at
the results of many studies to decide which medicines work best and are safest for patients.
1. Who Sponsored This Study?
Amgen, Inc.
One Amgen Center Drive
Thousand Oaks, CA 91320-1799 USA
Phone (United States): +1 805-447-1000
Amgen Inc., authorized marketer of etanercept in the United States and Canada and owner
of subsidiary Immunex Corporation, etanerceptâ€™s manufacturer, is the sponsor of the study.
Amgen would like to thank everyone who participated in this study and feels it is important to
share the results of this study.
1